NF-κB in Liver Cancer: The Plot Thickens

Abstract

The role of the NF-κB signaling pathway in liver cancer is complex. While some evidence suggests that in the liver, like in many other organ systems, NF-κB is oncogenic, there is strong evidence showing that in certain liver cancer models NF-κB suppresses tumorigenesis. These contrasting findings cannot be dismissed on technicalities and are likely due to the complex nature of the NF-κB response. Similar contrasting findings regarding NF-κB activity are revealed in skin cancer models. Thus, it is possible that the contradictory role of NF-κB in tumorigenesis is a general phenomenon and not an oddity related solely to the liver. Further studies are indicated to decipher the underlying molecular mechanisms. Revealing these mechanisms may facilitate the identification of patient subgroups and specific situations in which NF-κB inhibition will be a preferred therapeutic option. Moreover, it is possible that specific interventions could boost the tumor suppressor functions of NF-κB in tumors that harbor mutations that render this pathway constitutively active.

Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation

“…1A–B). Next, we compared tumor liver samples and adjacent liver parenchyma from an inflammation–induced liver cancer mouse model, Mdr2 −/− Mice (34,35). We found elevated levels of MALAT1 RNA in most of the liver tumor samples compared to the adjacent inflamed liver parenchyma from Mdr2 −/− mice (Fig.…”

Methyl-Cantharidimide Inhibits Growth of Human Hepatocellular Carcinoma Cells by Inducing Cell Cycle Arrest and Promoting Apoptosis

“…Thus, caspase-3 is essential for certain processes associated with the formation of apoptotic bodies, but it may also function before or at the stage when commitment to loss of cell viability is made (32, 33). NF-κB is a primary transcription factor which plays a key role in several cellular processes including cell proliferation and survival (34–36). In this study, 48 h after treatment of HepG2 cells with MCA, the protein level of cleaved-caspase3 was significantly increased while that of NF-κB was significantly decreased.…”

EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation

“…Persistent infections, activation of liver-resident macrophages (Kupffer cells) and recruitment of inflammatory cells can lead to chronic inflammation 5-8 accompanied by many factors favoring HCC development 9 . The molecular link between inflammation and HCC is not completely understood.…”